Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: The role of adenosine receptor A2

Cellular and Molecular Immunology

Volumn 7, Issue 1, 2010, Pages 77-82

  Sun, Jintang ^a   Zhang, Yan ^a,b   Yang, Meixiang ^a   Zhang, Yun ^a   Xie, Qi ^a   Li, Zewu ^a   Dong, Zhaogang ^a   Yang, Yongmei ^a   Deng, Biping ^a   Feng, Alei ^a   Hu, Weixu ^a   Mao, Haiting ^a   Qu, Xun ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Center for Disease Control and Prevention   (China)

Author keywords

Adenosine receptor; Apoptosis; CCR7; T cells

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; CHEMOKINE RECEPTOR CCR7; CCR7 PROTEIN, HUMAN; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT;

APOPTOSIS; ARTICLE; CELL SURVIVAL; HUMAN; HUMAN CELL; HYPOXIA; PROTEIN EXPRESSION; T LYMPHOCYTE; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; ANTINEOPLASTIC ACTIVITY; CELL FUNCTION; NONHUMAN;

APOPTOSIS; CELL HYPOXIA; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTORS, CCR7; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 75949098378     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.105     Document Type: Article

References (31)

1. Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int J Oncol 2008; 32: 527-535.
2. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 2005; 5: 712-721.
3. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177-182.
4. Zhao P, Li XG, Yang M, Shao Q, Wang D, Liu S et al. Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol 2008; 45: 2187-2195.
5. Qu X, Yang MX, Kong BH, Qi L, Lam QL, Yan S et al. Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol 2005; 83: 668-673.
6. Zhao W, Darmanin S, Fu Q, Chen J, Cui H, Wang J et al. Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocytederived dendritic cells. Eur J Immunol 2005; 35: 3468-3477.
7. Makino Y, Nakamura H, Ikeda E, Ohnuma K, Yamauchi K, Yabe Y et al. Hypoxiainducible factor regulates survival of antigen receptor-driven T cells. J Immunol 2003; 171: 6534-6540.
8. Naldini A, Carraro F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J Cell Physiol 1999; 181: 448-454.
9. Loeffler DA, Juneau PL, Masserant S. Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation. Br J Cancer 1992; 66: 619-622.
10. Zuckerberg AL, Goldberg LI, Lederman HM. Effects of hypoxia on interleukin-2mRNA expression by T lymphocytes. Crit Care Med 1994; 22: 197-203.
11. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 2001; 167: 6140-6149.
12. Kiang JG, Krishnan S, Lu X, Li Y. Inhibition of inducible nitric-oxide synthase protects human T cells from hypoxia-induced apoptosis. Mol Pharmacol 2008; 73: 738-747.
13. Gorlach A. Control of adenosine transport by hypoxia. Circ Res 2005; 97: 1-3.
14. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25: 33-39.
15. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004; 22: 657-682.
16. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001; 41: 775-787.
17. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
18. Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 2001; 19: 565-594.
19. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol 1999; 55: 614-624.
20. Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90: 1600-1610.
21. Sugiyama H, Chen P, Hunter M, Taffs R, Sitkovsky M. The dual role of the cAMPdependent protein kinase C alpha subunit in T-cell receptor-triggered T-lymphocytes effector functions. J Biol Chem 1992; 267: 25256-25263.
22. Benveniste P, Cohen A. p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc Natl Acad Sci USA 1995; 92: 8373-8377.
23. Apasov SG, Blackburn MR, Kellems RE, Smith PT, Sitkovsky MV. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest 2001; 108: 131-141.
24. Sallusto F, Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000; 177: 134-140.
25. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
26. Kim JW, Ferris RL, Whiteside TL. Chemokine C receptor 7 expression and protection of circulating CD81 T lymphocytes from apoptosis. Clin Cancer Res 2005; 11: 7901-7910.
27. Parmiani G, Castelli C, Rivoltini L. Chemokine receptor 7, a new player in regulating apoptosis of CD81 T cells in cancer patients. Clin Cancer Res 2005; 11: 7587-7588.
28. Mancino A, Schioppa T, Larghi P, Pasqualini F, Nebuloni M, Chen IH et al. Divergent effects of hypoxia on dendritic cell functions. Blood 2008; 112: 3723-3734.
29. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004; 104: 3986-3992.
30. Escribano C, Delgado-Martin C, Rodriguez-Fernandez JL. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta. J Immunol 2009; 183: 6282-6295.
31. Sánchez-Sánchez N, Riol-Blanco L, de la Rosa G, Puig-Kröger A, García-Bordas J, Martín D et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 2004; 104: 619-625.